insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.04
arrow_downward
-3.70%(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
TradingKey
·
10 hours ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
17 hours ago
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
2 hours ago
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com